Vimarsana
Biggest News Aggregation in the World

Page 14 - Week Range News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Week Range. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Week Range Today - Breaking & Trending Today

7 Best REITs To Buy Now For Times Of Uncertainty - Vimarsana News

7 Best REITs To Buy Now For Times Of Uncertainty

REITs are usually regarded as defensive stocks with resilience and stability. So, let's take a closer look at these seven REITs to buy.

7 Financial Stocks to Buy to Get Ready for the Fed's Next Move - Vimarsana News

7 Financial Stocks to Buy to Get Ready for the Fed's Next Move

Given that loan growth has been non-existent for the last year, rising interest rates are poised to push financial stocks higher.

7 Great Dividend Stocks To Buy In September For Insulation from Volatility - Vimarsana News

7 Great Dividend Stocks To Buy In September For Insulation from Volatility

Dividend stocks add stability to any portfolio, allowing income investors to sit back and collect cash regardless of market volatility

7 Fintech Stocks To Buy Before They Explode - Vimarsana News

7 Fintech Stocks To Buy Before They Explode

Source: Ark 52-Week Range: $33.37 – 64.49 Expense Ratio: 0.75% per year Our first choice is an exchange-traded fund (ETF). The ARK Fintech Innovation ETF is an actively managed fund run by Cathie Wood’s  Ark Invest. It invests in businesses that focus on the fintech sector. ARKF, which typically invests in 35-55 companies, currently has 43 holdings. The fund began trading in February 2019. The leading ten names account for more than 47% of net assets of $4 billion. Information technology (IT) has the highest sectoral allocation with 38.2%, followed by communication services (22.8%), ...

7 Growth Stocks to Buy As Meme Stock Mania Fades - Vimarsana News

7 Growth Stocks to Buy As Meme Stock Mania Fades

Growth stocks can be attractive additions to your long-term portfolio. However, any loss of confidence in their future performance typically leads to a significant and rapid price correction. Therefore, potential investors should do proper due diligence and be ready for volatility especially during the earnings season. Growth Stocks: Alkermes (ALKS) 52 week range: $15.35 — $25.74 Ireland-based biopharma group Alkermes has a portfolio of marketed drugs and a clinical pipeline of products that address central nervous system (CNS) disorders such as schizophrenia, depression, addiction, multipl...